This study leveraged 2 independent ataxia cohorts recruited via a large cross-European ataxia network to provide in-depth longitudinal phenotyping and quantitative natural history data on RFC1 disease, including preliminary sample size calculations, thus preparing the first steps toward trial readiness in this novel disease. This evidence concerns the gene RFC1 and cerebellar ataxia.